Drugs
Friday, 15 Nov 2019

Former Deputy Head of China's Drug Regulator Sentenced to 16 Years in Prison

Publisher: The Insight Partners

Wu Zhen, a former deputy head of China’s food and drug regulator, was sentenced to 16 years in prison by a Chinese court, state television reported on Friday.

Wu is one of the senior officials from the regulator who has been under investigation after a safety scandal at vaccine maker Changsheng Biotechnology Co Ltd.

The company was accused last year of falsifying data for a rabies vaccine and manufacturing an ineffective vaccine for babies, sparking widespread consumer anger.

Read here

Related Industry Updates

Takeda’s $1.7B AI Drug Discovery Deal with Iambic Signals Shift
Feb 10, 2026

New CBD Company, InnerGreen CBD, Paves the Way for Science-Based CBD
Jun 11, 2020

Neurotoxin Market is expected to reach US$ 13,195.06 million by 2028
May 09, 2023

North America Antibiotics Market Growth and Trends to 2020-2027 With Top Companies Like Johnson & Johnson Services, Inc, Bristol-Myers Squibb Company, Eli Lilly and Company., Abbott, Pfizer Inc
Dec 09, 2020

Europe Small Molecule Drug Delivery Market Opportunity Assessment and Forecast up to 2027
Sep 05, 2020

Drugmaker Sanofi to raise over $11 billion by selling its U.S. partner Regeneron shares
May 27, 2020

Antifungal Drugs Market is expected to reach US$ 13,997.4 Million in 2028
Jan 16, 2023

Follow us on

Related News

Medical / Jan 29, 2024

ADHD Therapeutics Market is expected to reach US$ 64,742.37 million by 2030

Medical / Apr 15, 2020

UnitedHealth rises on 'minimal' COVID-19 impact on results & maintained its forecast

Medical / Nov 08, 2023

Microbiome Therapeutics Market is expected to reach US$ 813.38 million by 2030

Medical / Sep 08, 2023

Acute Pancreatitis Market is expected to reach US$ 8,827.37 million by 2030